Literature DB >> 23472502

Modern management of epilepsy.

J P Leach1, H Abassi.   

Abstract

The expected quality of care for epilepsy has increased sharply in the last two decades, informed and directed by published guidance. Meeting these demands has become possible only by providing adequate numbers of consultants and nurses with the relevant expertise, alongside improvements in investigative facilities. The increasing choice of AEDs has been helpful in improving treatment options. Both primary and secondary care have an important role to play in easing diagnosis of new cases and highlighting cases where improvement in control are needed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23472502      PMCID: PMC5873717          DOI: 10.7861/clinmedicine.13-1-84

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  5 in total

1.  Epilepsy management: newer agents, unmet needs, and future treatment strategies.

Authors:  C Lee Ventola
Journal:  P T       Date:  2014-11

2.  Altered Expression of Intersectin1-L in Patients with Refractory Epilepsy and in Experimental Epileptic Rats.

Authors:  Xiaoyan Yang; Xin Xu; Yujiao Zhang; Shasha Wang; Minghui Li; Xuefeng Wang
Journal:  Cell Mol Neurobiol       Date:  2015-03-18       Impact factor: 5.046

3.  Abnormal Expression of FBXL20 in Refractory Epilepsy Patients and a Pilocarpine-Induced Rat Model.

Authors:  Pengfei Fu; YueTao Wen; Yan Xiong; Yanke Zhang; Haiyang Zhang; Yanfeng Xie; Quanhong Shi
Journal:  Neurochem Res       Date:  2016-08-08       Impact factor: 3.996

4.  Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.

Authors:  Antje Groth; Thomas Wilke; Simon Borghs; Patrick Gille; Lars Joeres
Journal:  Ger Med Sci       Date:  2017-06-12

5.  Seizure control of current shunt on rats with temporal lobe epilepsy and neocortical epilepsy.

Authors:  Limin Zhang; Shuli Liang; Guojun Zhang; Zhizhong Liu; Hong Lv; Fang Fang; Yajie Wang; Shaohui Zhang; Xixiong Kang
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.